Principal Financial Group
GEVA

Principal Financial Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Principal Financial Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$365K Buy
2014
Q4 		$319K Sell
2014
Q3 		$314K Buy
2014
Q2 		$399K Sell
2014
Q1 		$440K Sell
2013
Q4 		$346K Buy
2013
Q3 		$300K Sell
2013
Q2 		$259K Buy